GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.Patent Dispute Hammers ERAS Stock 48% as Law Firm Launches Shareholder Investigation
Patent infringement claim from Revolution Medicines triggers 48% stock collapse in Erasca, prompting shareholder investigation by law firm Bragar Eagel & Squire.
RVMDRVMDWERASsecurities investigationstock price decline